[go: up one dir, main page]

BRPI0802009E2 - aloe vera and alginate based pharmaceutical compositions and their uses - Google Patents

aloe vera and alginate based pharmaceutical compositions and their uses

Info

Publication number
BRPI0802009E2
BRPI0802009E2 BRC10802009A BRPI0802009A BRPI0802009E2 BR PI0802009 E2 BRPI0802009 E2 BR PI0802009E2 BR C10802009 A BRC10802009 A BR C10802009A BR PI0802009 A BRPI0802009 A BR PI0802009A BR PI0802009 E2 BRPI0802009 E2 BR PI0802009E2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
alginate based
aloe vera
based pharmaceutical
invention describes
Prior art date
Application number
BRC10802009A
Other languages
Portuguese (pt)
Inventor
Alfonso Gala García
Maria Esperanza Cortés Segura
Rubén Dario Sinisterra Millán
Sávio Morato De Lacerda Gontijo
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BRC10802009A priority Critical patent/BRPI0802009E2/en
Publication of BRPI0802009A2 publication Critical patent/BRPI0802009A2/en
Publication of BRPI0802009E2 publication Critical patent/BRPI0802009E2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

composições farmacêuticas à base de aloe vera e alginato e seus usos. a presente invenção descreve composições farmacêuticas à base de aioe vera e alginato contendo ou não fármacos. em seu aspecto mais geral, a presente invenção descreve composições farmacêuticas de aíginato/a/oe vera capazes de manterem as células viáveis no interior de sua matriz por até 30 dias, sendo de grande utilidade para diversos tipos celulares. as composições farmacêuticas contendo amoxicilina aumentam a viabilidade de osteobíastos, mantendo-os biologicamente ativos.aloe vera and alginate based pharmaceutical compositions and their uses. The present invention describes pharmaceutical and alginate based compositions containing or not drugs. In its most general aspect, the present invention describes pharmaceutical compositions of a / w / o and vera capable of maintaining viable cells within their matrix for up to 30 days and is of great use for various cell types. Amoxicillin-containing pharmaceutical compositions increase the viability of osteobasts, keeping them biologically active.

BRC10802009A 2008-04-30 2008-04-30 aloe vera and alginate based pharmaceutical compositions and their uses BRPI0802009E2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRC10802009A BRPI0802009E2 (en) 2008-04-30 2008-04-30 aloe vera and alginate based pharmaceutical compositions and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRC10802009A BRPI0802009E2 (en) 2008-04-30 2008-04-30 aloe vera and alginate based pharmaceutical compositions and their uses

Publications (2)

Publication Number Publication Date
BRPI0802009A2 BRPI0802009A2 (en) 2010-01-12
BRPI0802009E2 true BRPI0802009E2 (en) 2015-11-03

Family

ID=41509697

Family Applications (1)

Application Number Title Priority Date Filing Date
BRC10802009A BRPI0802009E2 (en) 2008-04-30 2008-04-30 aloe vera and alginate based pharmaceutical compositions and their uses

Country Status (1)

Country Link
BR (1) BRPI0802009E2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10857072B2 (en) 2016-10-31 2020-12-08 Imam Abdulrahman Bin Faisal University Dental composition and method of direct pulp capping

Also Published As

Publication number Publication date
BRPI0802009A2 (en) 2010-01-12

Similar Documents

Publication Publication Date Title
Koegler et al. The influence of nanostructured materials on biointerfacial interactions
BR112015001620A2 (en) culture medium composition, and method for culturing cell or tissue using said composition
TR201809514T4 (en) Long-term insulin formulations.
BRPI0717658A8 (en) AGROCHEMICAL FORMULATIONS DISPERSIBLE IN WATER, IN THE FORM OF A SUSPENSION CONCENTRATE AND IN THE FORM OF GRANULES DISPERSIBLE IN WATER, AND THEIR USE
MX2010004613A (en) Topical composition.
BR112012030818A2 (en) "modified c-3 betulinic acid derivatives as inhibitors of hiv maturation"
CO6311008A2 (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +
BR112015026601A2 (en) method for a cell-based drug screening assay and the use of the same
BR112015011158A8 (en) triazolopyrazine, its use and pharmaceutical preparation
ATE499090T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING HYDROCHLOROTHIAZIDE AND TELMISARTAN
BR112015021757A2 (en) molecules having certain pesticidal uses, and intermediates, compositions, and processes related thereto
BR112012018695A2 (en) pyrazole compounds as crth2 antagonists
BR112015006524A8 (en) quinazolinone derivatives as parp inhibitors, their preparation process, their use, medications and kit
UY31530A (en) "RETICULATED POLYAMINS AND THEIR USES IN PHARMACEUTICAL COMPOSITIONS"
BR112012030064A2 (en) active principle application system
CL2008002984A1 (en) Pharmaceutical composition comprising mycophenolate sodium and its use for the treatment and / or prevention of autoimmune diseases such as rejection of allografts or xenografts of organs, cells or tissues and as an anti-inflammatory.
BR112014020416A2 (en) 1-(2-DESOXY-2-FLUOR-4-THIO-B-D-ARABINOFUURANOSYL) SALT
BR112014030286A2 (en) anti-reflux additives and propellants comprising rapidly calcined clay, manufacturing methods and methods of use
BR112013030567A2 (en) bioartificial proximal tubule systems and methods of use
BRPI0821373B8 (en) pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes
BR112012006056A2 (en) dosage form
Stan et al. Formulation and comprehensive evaluation of biohybrid hydrogel membranes containing doxycycline or silver nanoparticles
BRPI0802009E2 (en) aloe vera and alginate based pharmaceutical compositions and their uses
AR061802A1 (en) COMPOSITION THAT HAS AN ACTIVITY THAT PREVENTS GERMINATION, PROCEDURES FOR OBTAINING SUCH COMPOSITIONS AND USE OF THE SAME
AR062626A1 (en) SULFONATE POLYSTYRENE POLYMER TABLETS, ITS PREPARATION AND USE

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR A RETRIBUICAO DAS 4A E 6A ANUIDADES DE ACORDO COM TABELA VIGENTE , REFERENTE AS GUIAS DE RECOLHIMENTO 221106985286 E 22130994393.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2438 DE 26/09/2017.

B11Q Dismissal: the certificate of addition was not accessory to any patent, or a patent which was nominated accessory and no longer exists

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: ARQUIVO DO PRESENTE PEDIDO FACE A MANUTENCAO DO ARQUIVAMENTO DO PEDIDO PRINCIPAL (PI0802009-4)

B11T Dismissal: dismissal of application maintained

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: